CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

TABUK Pharmaceuticals

TABUK Pharmaceuticals is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inno Supps

Inno Supps is a natural supplement company based in Las Vegas that offers top tier products with clean, natural ingredients for athletes and individuals of all ages.

Family Care Center

Family Care Center provides counseling, medication management, and TMS. We specialize in mental health care for the entire family. Call today to learn more.

Lyne Laboratories

Lyne Laboratories is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vista Pharmaceuticals

Vista Pharmaceuticals is a West Orange, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.